Effects of Zeolite and Deficit Irrigation on Sweet Pepper Growth

The use of zeolites in agriculture as a soil conditioner is becoming an important field of research in crop growth. To study the effect of synthetic zeolites and deficit irrigation on sweet pepper (Capsicum annuum L.) cultivation, an experiment was conducted in a controlled environment. In particular, sweet peppers were cultivated in a glasshouse using polypropylene pots filled with sandy loam soil, to which 2% zeolite was added. The zeolite employed in the experiments was obtained using coal fly ash as a raw material. The experiment consisted of two main treatments: (a) soil with a zeolite at 2% (Z) and (b) soil without a zeolite as a control (C). Three subplot treatments consisted of (1) full irrigation at 100% of the available water content (AWC) (100); (2) deficit irrigation at 70% of the AWC (70); and (3) deficit irrigation at 50% of the AWC (50). Sweet pepper cultivation started on 24 April 2023 and lasted until 23 June 2023; during the trial, the environmental data, such as the soil humidity, air temperature, and relative humidity, and some crop parameters, such as the plant height, leaf number, and the SPAD index, were monitored. At the end of the trial, the fresh and dry plant weights, the dry matter content, and the leaf water potential were measured. The results showed that, for the plant fresh weight and dry matter content, no significant differences were observed in the treatments and their interactions, whereas, for the other parameters, the statistical analysis showed significant differences. The study suggests that the soil’s structural benefits, resulting from zeolite application, are not followed by an equal positive effect in terms of sweet pepper growth under deficit irrigation conditions

Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

Background and objective: Chronic obstructive pulmonary disease (COPD) and heart failure (HF) mutually increase the risk of being present in the same patient, especially if older. Whether or not this coexistence may be associated with a worse prognosis is debated. Therefore, employing data derived from the REPOSI register, we evaluated the clinical features and outcomes in a population of elderly patients admitted to internal medicine wards and having COPD, HF or COPD + HF. Methods: We measured socio-demographic and anthropometric characteristics, severity and prevalence of comorbidities, clinical and laboratory features during hospitalization, mood disorders, functional independence, drug prescriptions and discharge destination. The primary study outcome was the risk of death. Results: We considered 2,343 elderly hospitalized patients (median age 81 years), of whom 1,154 (49%) had COPD, 813 (35%) HF, and 376 (16%) COPD + HF. Patients with COPD + HF had different characteristics than those with COPD or HF, such as a higher prevalence of previous hospitalizations, comorbidities (especially chronic kidney disease), higher respiratory rate at admission and number of prescribed drugs. Patients with COPD + HF (hazard ratio HR 1.74, 95% confidence intervals CI 1.16-2.61) and patients with dementia (HR 1.75, 95% CI 1.06-2.90) had a higher risk of death at one year. The Kaplan-Meier curves showed a higher mortality risk in the group of patients with COPD + HF for all causes (p = 0.010), respiratory causes (p = 0.006), cardiovascular causes (p = 0.046) and respiratory plus cardiovascular causes (p = 0.009). Conclusion: In this real-life cohort of hospitalized elderly patients, the coexistence of COPD and HF significantly worsened prognosis at one year. This finding may help to better define the care needs of this population

Analysis of prognostic factors in surgically resected N1 non small cell lung cancer

n

New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond

Non-muscle-invasive bladder cancer (NMIBC) is characterized by a high rate of cure, but also by a non-negligible probability of recurrence and risk progression to muscle-invasive disease. NMIBC management requires a proper local resection and staging, followed by a risk-based treatment with intravesical agents. For many years, the current gold standard treatment for patients with intermediate or high-risk disease is transurethral resection of the bladder (TURB) followed by intravesical bacillus Calmette–Guérin (BCG) instillations. Unfortunately, in about half of high-risk patients, intravesical BCG treatment fails and NMIBC persists or recurs early. While radical cystectomy remains the gold standard for these patients, new therapeutic targets are being individuated and studied. Radical cystectomy in fact can provide an excellent long-term disease control, but can deeply interfere with quality of life. In particular, the enhanced immune checkpoints expression shown in BCG-unresponsive patients and the activity of immune checkpoints inhibitors (ICIs) in advanced bladder cancer provided the rationale for testing ICIs in NMIBC. Recently, pembrolizumab has shown promising activity in BCG-unresponsive NMIBC patients, obtaining FDA approval. Meanwhile multiple novel drugs with alternative mechanisms of action have proven to be safe and effective in NMIBC treatment and others are under investigation. The aim of this review is to analyse and describe the clinical activity of new emerging drugs in BCG-unresponsive NMIBC focusing on immunotherapy results

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside

Significant progress has been achieved over the last decades in understanding the biology and mechanisms of tumor progression in urothelial carcinoma (UC). Although the therapeutic landscape has dramatically changed in recent years with the introduction of immune checkpoint inhibitors, advanced UC is still associated with rapidly progressing disease and poor survival. The increasing knowledge of the pathogenesis and molecular pathways underlying cancer development and progression is leading the introduction of target therapies, such as the recently approved FGFR inhibitor Erdafitinib, or the anti-nectin 4 antibody drug-conjugate Enfortumab vedotin. Antibody drug conjugates represent an innovative therapeutic approach that allows the combination of a tar get-specific monoclonal antibody covalently conjugated via a linker to a cytotoxic agent (payload). UC is a perfect candidate for this therapeutic approach since it is particularly enriched in antigen expression on its surface and each specific antigen can represent a potential therapeutic target. In this review we summarize the mechanism of action of ADCs, their applications in localized and metastatic UC, the main mechanisms of resistance, and future perspectives for their use in clinical practice

Lipid Nanocarriers-Loaded Nanocomposite as a Suitable Platform to Release Antibacterial and Antioxidant Agents for Immediate Dental Implant Placement Restorative Treatment

Immediate implant placement is a single-stage restorative approach for missing teeth widely used to overcome the ridge remodeling process occurring after dental extractions. The success of this procedure relies on opportune osseointegration in the surrounding tissues. To support this process, a multifunctional nanocomposite, to be applied in the fresh post-extraction socket, was here designed, prepared, and characterized. This formulation consists of quercetin (QRC)-loaded nanostructured lipid carriers (NLCs) entrapped in a chitosan-based solid matrix containing ciprofloxacin (CPX). QRC-NLCs were prepared by homogenization followed by high-frequency sonication, and thereafter this dispersion was trapped in a chitosan-based CPX-loaded gel, obtaining the nanocomposite powder (BioQ-CPX) by lyophilization. BioQ-CPX displayed desirable properties such as high porosity (94.1 ± 0.5%), drug amounts (2.1% QRC and 3.5% CPX). and low swelling index (100%). Moreover, the mechanism of drug release from BioQ-CPX and their ability to be accumulated in the target tissue were in vitro and ex vivo elucidated, also by applying mathematical models. When trapped into the nanocomposite, QRC stressed under UV light exposure (50 W) was shown to maintain its antioxidant power, and CPX and QRC under natural light were stable over nine months. Finally, both the measured antioxidant power and the antimicrobial and antibiofilm properties on Staphylococcus aureus demonstrated that BioQ-CPX could be a promising platform to support the single-stage dental restorative treatment

FORME DELL’ABITARE A ROMA. ECHI DELL’ANTICO NELL’ARCHITETTURA DEL PRIMO NOVECENTO.

Il convegno intende focalizzare l’attenzione sul tema dell'architettura residenziale a Roma mettendo in relazione gli studi sulle tipologie e sul linguaggio architettonico dell'antichità con le esperienze dei primi decenni del Novecento, realizzate contestualmente allo sviluppo abitativo della Capitale. Sebbene l'architettura di Roma imperiale e quella della Capitale postunitaria siano due realtà lontane sul piano cronologico, trovano un punto di contatto nella fortuna di cui l’antico ha goduto in quanto modello per applicazioni e sperimentazioni progettuali. Mai nella storia dell’edilizia abitativa come nel primo Novecento la riscoperta di interi isolati di abitazioni – in particolar modo a Ostia i «caseggiati» riportati alla luce dagli scavi sistematici di Dante Vaglieri fino a quelli di Guido Calza e di Italo Gismondi nel primo dopoguerra – influenzò la progettazione architettonica coeva, non soltanto sotto l’aspetto formale

Esmolol in Cardiac Surgery: A Randomized Controlled Trial

To assess whether the administration of the ultra-short-acting β-blocker esmolol in cardiac surgery could have a cardioprotective effect that translates into improved postoperative outcomes